314 related articles for article (PubMed ID: 28064239)
1. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239
[TBL] [Abstract][Full Text] [Related]
2. DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.
Valle-Argos B; Chiodin G; Bryant DJ; Taylor J; Lemm E; Duriez PJ; Rock PJ; Strefford JC; Forconi F; Burack RW; Packham G; Stevenson FK
Sci Rep; 2021 Jun; 11(1):11676. PubMed ID: 34083646
[TBL] [Abstract][Full Text] [Related]
3. Mutations in V-ATPase in follicular lymphoma activate autophagic flux creating a targetable dependency.
Wang F; Yang Y; Klionsky DJ; Malek SN
Autophagy; 2023 Feb; 19(2):716-719. PubMed ID: 35482846
[TBL] [Abstract][Full Text] [Related]
4. EZH2 mutations are frequent and represent an early event in follicular lymphoma.
Bödör C; Grossmann V; Popov N; Okosun J; O'Riain C; Tan K; Marzec J; Araf S; Wang J; Lee AM; Clear A; Montoto S; Matthews J; Iqbal S; Rajnai H; Rosenwald A; Ott G; Campo E; Rimsza LM; Smeland EB; Chan WC; Braziel RM; Staudt LM; Wright G; Lister TA; Elemento O; Hills R; Gribben JG; Chelala C; Matolcsy A; Kohlmann A; Haferlach T; Gascoyne RD; Fitzgibbon J
Blood; 2013 Oct; 122(18):3165-8. PubMed ID: 24052547
[TBL] [Abstract][Full Text] [Related]
5. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
Bouska A; Zhang W; Gong Q; Iqbal J; Scuto A; Vose J; Ludvigsen M; Fu K; Weisenburger DD; Greiner TC; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Wu CI; Staudt LM; D'Amore F; McKeithan TW; Chan WC
Leukemia; 2017 Jan; 31(1):83-91. PubMed ID: 27389057
[TBL] [Abstract][Full Text] [Related]
6. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.
Okosun J; Wolfson RL; Wang J; Araf S; Wilkins L; Castellano BM; Escudero-Ibarz L; Al Seraihi AF; Richter J; Bernhart SH; Efeyan A; Iqbal S; Matthews J; Clear A; Guerra-Assunção JA; Bödör C; Quentmeier H; Mansbridge C; Johnson P; Davies A; Strefford JC; Packham G; Barrans S; Jack A; Du MQ; Calaminici M; Lister TA; Auer R; Montoto S; Gribben JG; Siebert R; Chelala C; Zoncu R; Sabatini DM; Fitzgibbon J
Nat Genet; 2016 Feb; 48(2):183-8. PubMed ID: 26691987
[TBL] [Abstract][Full Text] [Related]
7. KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and malignant germinal center B cells.
Vlasevska S; Garcia-Ibanez L; Duval R; Holmes AB; Jahan R; Cai B; Kim A; Mo T; Basso K; Soni RK; Bhagat G; Dalla-Favera R; Pasqualucci L
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2218330120. PubMed ID: 36893259
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
Krull JE; Wenzl K; Hopper MA; Manske MK; Sarangi V; Maurer MJ; Larson MC; Mondello P; Yang Z; Novak JP; Serres M; Whitaker KR; Villasboas Bisneto JC; Habermann TM; Witzig TE; Link BK; Rimsza LM; King RL; Ansell SM; Cerhan JR; Novak AJ
Cell Rep Med; 2024 Mar; 5(3):101443. PubMed ID: 38428430
[TBL] [Abstract][Full Text] [Related]
9. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Crouch S; Painter D; Barrans SL; Roman E; Beer PA; Cooke SL; Glover P; Van Hoppe SJL; Webster N; Lacy SE; Ruiz C; Campbell PJ; Hodson DJ; Patmore R; Burton C; Smith A; Tooze RM
Blood Adv; 2022 Nov; 6(21):5716-5731. PubMed ID: 35363872
[TBL] [Abstract][Full Text] [Related]
10. Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor.
Haebe S; Day G; Czerwinski DK; Sathe A; Grimes SM; Chen T; Long SR; Martin B; Ozawa MG; Ji HP; Shree T; Levy R
Blood; 2023 Dec; 142(26):2296-2304. PubMed ID: 37683139
[TBL] [Abstract][Full Text] [Related]
11. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
Los-de Vries GT; Stevens WBC; van Dijk E; Langois-Jacques C; Clear AJ; Stathi P; Roemer MGM; Mendeville M; Hijmering NJ; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Horn H; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; de Jong D
Blood Adv; 2022 Sep; 6(18):5482-5493. PubMed ID: 35816682
[TBL] [Abstract][Full Text] [Related]
12. Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.
Horton SJ; Giotopoulos G; Yun H; Vohra S; Sheppard O; Bashford-Rogers R; Rashid M; Clipson A; Chan WI; Sasca D; Yiangou L; Osaki H; Basheer F; Gallipoli P; Burrows N; Erdem A; Sybirna A; Foerster S; Zhao W; Sustic T; Petrunkina Harrison A; Laurenti E; Okosun J; Hodson D; Wright P; Smith KG; Maxwell P; Fitzgibbon J; Du MQ; Adams DJ; Huntly BJP
Nat Cell Biol; 2017 Sep; 19(9):1093-1104. PubMed ID: 28825697
[TBL] [Abstract][Full Text] [Related]
13. The essential microenvironmental role of oligomannoses specifically inserted into the antigen-binding sites of lymphoma cells.
Stevenson FK; Forconi F
Blood; 2024 Mar; 143(12):1091-1100. PubMed ID: 37992212
[TBL] [Abstract][Full Text] [Related]
14. Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma.
Briest F; Noerenberg D; Hennch C; Yoshida K; Hablesreiter R; Nimo J; Sasca D; Kirchner M; Mansouri L; Inoue Y; Wiegand L; Staiger AM; Casadei B; Korkolopoulou P; Weiner J; Lopez-Guillermo A; Warth A; Schneider T; Nagy Á; Klapper W; Hummel M; Kanellis G; Anagnostopoulos I; Mertins P; Bullinger L; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
Leukemia; 2023 Nov; 37(11):2237-2249. PubMed ID: 37648814
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.
Araf S; Wang J; Korfi K; Pangault C; Kotsiou E; Rio-Machin A; Rahim T; Heward J; Clear A; Iqbal S; Davies JK; Johnson P; Calaminici M; Montoto S; Auer R; Chelala C; Gribben JG; Graham TA; Fest T; Fitzgibbon J; Okosun J
Leukemia; 2018 May; 32(5):1261-1265. PubMed ID: 29568095
[No Abstract] [Full Text] [Related]
16. Energy overpowers sweet tooth in FL.
Veelken H
Blood; 2023 Dec; 142(26):2226-2229. PubMed ID: 38153769
[No Abstract] [Full Text] [Related]
17. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Reddy A; Zhang J; Davis NS; Moffitt AB; Love CL; Waldrop A; Leppa S; Pasanen A; Meriranta L; Karjalainen-Lindsberg ML; Nørgaard P; Pedersen M; Gang AO; Høgdall E; Heavican TB; Lone W; Iqbal J; Qin Q; Li G; Kim SY; Healy J; Richards KL; Fedoriw Y; Bernal-Mizrachi L; Koff JL; Staton AD; Flowers CR; Paltiel O; Goldschmidt N; Calaminici M; Clear A; Gribben J; Nguyen E; Czader MB; Ondrejka SL; Collie A; Hsi ED; Tse E; Au-Yeung RKH; Kwong YL; Srivastava G; Choi WWL; Evens AM; Pilichowska M; Sengar M; Reddy N; Li S; Chadburn A; Gordon LI; Jaffe ES; Levy S; Rempel R; Tzeng T; Happ LE; Dave T; Rajagopalan D; Datta J; Dunson DB; Dave SS
Cell; 2017 Oct; 171(2):481-494.e15. PubMed ID: 28985567
[TBL] [Abstract][Full Text] [Related]
18. Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.
Bartlett NL; Costello BA; LaPlant BR; Ansell SM; Kuruvilla JG; Reeder CB; Thye LS; Anderson DM; Krysiak K; Ramirez C; Qi J; Siegel BA; Griffith M; Griffith OL; Gomez F; Fehniger TA
Blood; 2018 Jan; 131(2):182-190. PubMed ID: 29074501
[TBL] [Abstract][Full Text] [Related]
19. Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.
Korfi K; Ali S; Heward JA; Fitzgibbon J
Epigenetics; 2017 May; 12(5):370-377. PubMed ID: 28106467
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
